These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Differences between ante mortem Alzheimer's disease biomarkers in predicting neuropathology at autopsy. Wang ZB; Tan L; Wang HF; Chen SD; Fu Y; Gao PY; Ma YH; Guo Y; Hou JH; Zhang DD; Yu JT; Alzheimers Dement; 2023 Aug; 19(8):3613-3624. PubMed ID: 36840620 [TBL] [Abstract][Full Text] [Related]
8. Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuum. Gobom J; Benedet AL; Mattsson-Carlgren N; Montoliu-Gaya L; Schultz N; Ashton NJ; Janelidze S; Servaes S; Sauer M; Pascoal TA; Karikari TK; Lantero-Rodriguez J; Brinkmalm G; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K Mol Neurodegener; 2022 Dec; 17(1):81. PubMed ID: 36510321 [TBL] [Abstract][Full Text] [Related]
9. Localization of PDE4D, HCN1 channels, and mGluR3 in rhesus macaque entorhinal cortex may confer vulnerability in Alzheimer's disease. Datta D; Perone I; Morozov YM; Arellano J; Duque A; Rakic P; van Dyck CH; Arnsten AFT Cereb Cortex; 2023 Dec; 33(24):11501-11516. PubMed ID: 37874022 [TBL] [Abstract][Full Text] [Related]
10. ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration. Cousins KAQ; Irwin DJ; Wolk DA; Lee EB; Shaw LMJ; Trojanowski JQ; Da Re F; Gibbons GS; Grossman M; Phillips JS Brain; 2020 Jul; 143(7):2295-2311. PubMed ID: 32666090 [TBL] [Abstract][Full Text] [Related]
11. Development of immunoprecipitation - two-dimensional liquid chromatography - mass spectrometry methodology as biomarker read-out to quantify phosphorylated tau in cerebrospinal fluid from Alzheimer disease patients. Bijttebier S; Theunis C; Jahouh F; Martins DR; Verhemeldonck M; Grauwen K; Dillen L; Mercken M J Chromatogr A; 2021 Aug; 1651():462299. PubMed ID: 34107398 [TBL] [Abstract][Full Text] [Related]
12. A novel tau-based rhesus monkey model of Alzheimer's pathogenesis. Beckman D; Chakrabarty P; Ott S; Dao A; Zhou E; Janssen WG; Donis-Cox K; Muller S; Kordower JH; Morrison JH Alzheimers Dement; 2021 Jun; 17(6):933-945. PubMed ID: 33734581 [TBL] [Abstract][Full Text] [Related]
13. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology. Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C; Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532 [TBL] [Abstract][Full Text] [Related]
14. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus. Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890 [TBL] [Abstract][Full Text] [Related]
16. Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration. Fernández-Cabello S; Kronbichler M; Van Dijk KRA; Goodman JA; Spreng RN; Schmitz TW; Brain; 2020 Mar; 143(3):993-1009. PubMed ID: 32203580 [TBL] [Abstract][Full Text] [Related]
17. Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels. Murray ME; Moloney CM; Kouri N; Syrjanen JA; Matchett BJ; Rothberg DM; Tranovich JF; Sirmans TNH; Wiste HJ; Boon BDC; Nguyen AT; Reichard RR; Dickson DW; Lowe VJ; Dage JL; Petersen RC; Jack CR; Knopman DS; Vemuri P; Graff-Radford J; Mielke MM Mol Neurodegener; 2022 Dec; 17(1):85. PubMed ID: 36575455 [TBL] [Abstract][Full Text] [Related]
18. Blood tau-PT217 contributes to the anesthesia/surgery-induced delirium-like behavior in aged mice. Lu J; Liang F; Bai P; Liu C; Xu M; Sun Z; Tian W; Dong Y; Zhang Y; Quan Q; Khatri A; Shen Y; Marcantonio E; Crosby G; Culley DJ; Wang C; Yang G; Xie Z Alzheimers Dement; 2023 Sep; 19(9):4110-4126. PubMed ID: 37249148 [TBL] [Abstract][Full Text] [Related]
19. Age-related calcium dysregulation linked with tau pathology and impaired cognition in non-human primates. Datta D; Leslie SN; Wang M; Morozov YM; Yang S; Mentone S; Zeiss C; Duque A; Rakic P; Horvath TL; van Dyck CH; Nairn AC; Arnsten AFT Alzheimers Dement; 2021 Jun; 17(6):920-932. PubMed ID: 33829643 [TBL] [Abstract][Full Text] [Related]
20. Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum. Milà-Alomà M; Salvadó G; Gispert JD; Vilor-Tejedor N; Grau-Rivera O; Sala-Vila A; Sánchez-Benavides G; Arenaza-Urquijo EM; Crous-Bou M; González-de-Echávarri JM; Minguillon C; Fauria K; Simon M; Kollmorgen G; Zetterberg H; Blennow K; Suárez-Calvet M; Molinuevo JL; Alzheimers Dement; 2020 Oct; 16(10):1358-1371. PubMed ID: 32573951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]